These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25963934)

  • 21. Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation.
    Kurokawa M; Nishiyama K; Koga Y; Eguchi K; Imai T; Oba U; Shiraishi A; Nagata H; Kaku N; Ishimura M; Honjo S; Ohga S
    Pediatr Nephrol; 2020 Oct; 35(10):1977-1984. PubMed ID: 32488669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation.
    Lugthart G; Jordans CCE; de Pagter APJ; Bresters D; Jol-van der Zijde CM; Bense JE; van Rooij-Kouwenhoven RWG; Sukhai RN; Louwerens M; Dorresteijn EM; Lankester AC
    Kidney Int; 2021 Oct; 100(4):906-914. PubMed ID: 34102218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience.
    Kang SH; Park HS; Sun IO; Choi SR; Chung BH; Choi BS; Min CK; Do JY; Yang CW; Kim YS; Yoon KW; Park CW
    Clin Nephrol; 2012 Mar; 77(3):225-30. PubMed ID: 22377254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.
    Zhou W; Sultana R; Diong C; Goh YT; Gopalakrishnan S; Ho A; Hwang W; Koh LP; Koh M; Loh Y; Tan P; Linn YC
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and influencing factors of cyclosporine A on the kidney injury following allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Lu R; Shi Y; Yang M; Yang N; He S; Xin L; Qin Y; Li H; Zeng L; Zou K; Yang C; Huang L; Shi W; Qiu X; Lu X; Zhang L
    Int Immunopharmacol; 2023 Sep; 122():110633. PubMed ID: 37451015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome predictors of allogeneic hematopoietic stem cell transplant.
    Yang WC; Chen YT; Chang WW; Chang CH; Fan PC; Lee SY; Kao KC; Tian YC; Hung CC; Fang JT; Yang CW; Chen YC; Wang PN
    Am J Med Sci; 2013 Jan; 345(1):33-8. PubMed ID: 22475735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!
    Kindwall-Keller TL; Ballen KK
    Oncologist; 2017 Sep; 22(9):1125-1134. PubMed ID: 28546462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant.
    Ahmed I; Teruya J; Murray-Krezan C; Krance R
    Pediatr Transplant; 2015 Jun; 19(4):391-8. PubMed ID: 25809012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary elafin and kidney injury in hematopoietic cell transplant recipients.
    Hingorani S; Finn LS; Pao E; Lawler R; Schoch G; McDonald GB; Najafian B; Sandmaier B; Gooley T
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):12-20. PubMed ID: 25388519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of low doses of methotrexate during peri-cell infusion period may be a risk factor for acute kidney injury in patients subjected to hematopoietic stem cell transplantation.
    Ferraz FTP; Marra AR; Hamerschlak N; de Souza Durão Junior M
    Ann Hematol; 2020 Mar; 99(3):627-633. PubMed ID: 31965273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.
    Oliver N; Luong T; Tchakarov A; Abdelrahim M; Mulanovich VE; Kontoyiannis DP; Jones R; Kebriaei P; Samuels J; Glass W; Abudayyeh A
    Bone Marrow Transplant; 2016 Oct; 51(10):1301-1304. PubMed ID: 27159179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute kidney injury after allogeneic hematopoietic stem cell transplantation - Predictors and survival impact: A single center retrospective study.
    Menezes MDM; Marques AI; Chuva T; Pinho Vaz C; Ferreira H; Branca R; Paiva A; Campos A; Maximino Costa J
    Nefrologia (Engl Ed); 2022; 42(6):656-663. PubMed ID: 36402680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for chronic kidney disease following acute kidney injury in pediatric allogeneic hematopoietic cell transplantation.
    Prasad M; Jain NG; Radhakrishnan J; Jin Z; Satwani P
    Bone Marrow Transplant; 2021 Jul; 56(7):1665-1673. PubMed ID: 33627796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
    Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-transplantation of multipotent mesenchymal stromal cells in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Kallekleiv M; Larun L; Bruserud Ø; Hatfield KJ
    Cytotherapy; 2016 Feb; 18(2):172-85. PubMed ID: 26794711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of kidney complications and analysis of hypertension in children with allogeneic hematopoietic stem cell transplantation.
    Gurbanov A; Gülhan B; Kuşkonmaz B; Okur FV; Ozaltin F; Düzova A; Çetinkaya DU; Topaloglu R
    Pediatr Nephrol; 2023 Feb; 38(2):461-469. PubMed ID: 35596092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute kidney injury and risk factors in pediatric patients undergoing hematopoietic stem cell transplantation.
    Avcı B; Bilir ÖA; Özlü SG; Kanbur ŞM; Gökçebay DG; Bozkaya İO; Bayrakçı US; Özbek NY
    Pediatr Nephrol; 2024 Jul; 39(7):2199-2207. PubMed ID: 38324191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.